A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may increase the risk of pulmonary aspiration among patients undergoing surgery ...

Researchers from the Institute of Science Tokyo and Osaka Medical and Pharmaceutical University said that they have developed a peptide that can bind to the spike proteins of SARS-CoV-2 to prevent ...

Every country’s growth and progress are based on education, and Nigeria’s educational system confirms that. Nigeria’s education framework has experienced tremendous transformation over the years. It ...

She was prescribed compound semaglutide, a cheaper, custom-made version of the active drug in Ozempic and Wegovy, in May 2022 and lost a staggering 64lbs in six months. But then she made a big ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy. The notice was issued on Tuesday ...

The weight loss drug semaglutide was a "miracle" for Staci Rice. Her cravings and "food noise" disappeared, and it help her lose 64 pounds in around eight months. But, even in its cheaper forms ...

have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and also antiobesity treatment. Commercially available therapeutic lipidated GLP-1 analogues, semaglutide and ...

But the semaglutide-like drugs also appear to increase the risk of many others. Glucagon-like peptide 1 receptor agonists (called simply GLP-1RAs), the class to which those drugs and others including ...